Cargando…
Neutrophil‐lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients
Several studies have demonstrated the prognostic value of neutrophil‐lymphocyte ratio (NLR) in patients with solid tumors and non–Hodgkin lymphoma. In contrast, there is only sparse data on its prognostic role in patients with classical Hodgkin lymphoma (cHL). The aim of our study was to establish w...
Autores principales: | Marcheselli, Raffaella, Bari, Alessia, Tadmor, Tamar, Marcheselli, Luigi, Cox, Maria Christina, Pozzi, Samantha, Ferrari, Angela, Baldini, Luca, Gobbi, Paolo, Aviv, Ariel, Pugliese, Giuseppe, Federico, Massimo, Polliack, Aaron, Sacchi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763313/ https://www.ncbi.nlm.nih.gov/pubmed/27791277 http://dx.doi.org/10.1002/hon.2359 |
Ejemplares similares
-
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma
por: Marcheselli, Raffaella, et al.
Publicado: (2020) -
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
por: Bari, Alessia, et al.
Publicado: (2016) -
Therapy-Related Myeloid Neoplasm in Non-Hodgkin Lymphoma Survivors
por: Bari, Alessia, et al.
Publicado: (2011) -
Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
por: Marcheselli, Raffaella, et al.
Publicado: (2015) -
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines
por: Cosenza, Maria, et al.
Publicado: (2016)